144 related articles for article (PubMed ID: 18586664)
1. Biodegradable coating for drug-eluting stents--more than a facelift?
Niemelä KO
Eur Heart J; 2008 Aug; 29(16):1930-1. PubMed ID: 18586664
[No Abstract] [Full Text] [Related]
2. Polymer coating techniques for drug-eluting stents.
al-Lamee K; Cook D
Med Device Technol; 2003; 14(1):12-4. PubMed ID: 12974119
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus-eluting coronary stents.
Sharma S; Bhambi B; Nyitray W
N Engl J Med; 2002 Oct; 347(16):1285; author reply 1285. PubMed ID: 12393833
[No Abstract] [Full Text] [Related]
5. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
[No Abstract] [Full Text] [Related]
6. Newer stents: looking at the horizon.
Ramcharitar S; Serruys PW
Indian Heart J; 2007; 59(2 Suppl B):B59-71. PubMed ID: 19153438
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
8. Towards defining the role of drug eluting stents.
Tarantini G; Ramondo A; Razzolini R
Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
[No Abstract] [Full Text] [Related]
9. Restenosis and drug-eluting stents.
Winslow RD; Sharma SK; Kim MC
Mt Sinai J Med; 2005 Mar; 72(2):81-9. PubMed ID: 15770337
[TBL] [Abstract][Full Text] [Related]
10. [Drug eluting stents--end of restenosis?].
Groch L
Vnitr Lek; 2004 Oct; 50 Suppl 1():S59-62. PubMed ID: 15651142
[No Abstract] [Full Text] [Related]
11. [Development of drug coating on drug eluting stents].
Luo LL; Wang GX; Yin TY
Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
[TBL] [Abstract][Full Text] [Related]
12. A critical appraisal of the safety and efficacy of drug-eluting stents.
Maluenda G; Lemesle G; Waksman R
Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable drug-eluting stents: promises and pitfalls.
Di Mario C; Ferrante G
Lancet; 2008 Mar; 371(9616):873-4. PubMed ID: 18342665
[No Abstract] [Full Text] [Related]
14. [Biodegradable polymer-coated - new step in coronary arteriosclerosis intervention].
Siminiak T
Kardiol Pol; 2010 May; 68(5):510-1. PubMed ID: 20491009
[No Abstract] [Full Text] [Related]
15. Off-label use of drug-eluting stents putting it in perspective.
Grines CL
J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
[No Abstract] [Full Text] [Related]
16. Drug-eluting stents for secondary prevention of restenosis.
Kastrati A
Catheter Cardiovasc Interv; 2004 Nov; 63(3):265-6. PubMed ID: 15505858
[No Abstract] [Full Text] [Related]
17. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
Jabara R; Chronos N; Robinson K
Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
[TBL] [Abstract][Full Text] [Related]
18. Pathology of drug-eluting stents: implications for coronary intervention.
Finn AV; Nakazawa G; Virmani R
Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436
[TBL] [Abstract][Full Text] [Related]
19. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
Zhang F; Qian J; Ge J
J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents: effective and safe for every patient and every lesion?
Zeymer U; Zahn R
Eur Heart J; 2007 Nov; 28(21):2559-60. PubMed ID: 17938127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
